The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medical Non-ionic Contrast Agent Market Research Report 2024
Synopsis
Due to the improvement of the chemical structure, non-ionic contrast agents have two main advantages over ionic contrast agents: most of the adverse reactions of contrast agents are related to high osmosis and charging. The distinguishing feature of non-ionic contrast agents is low osmotic pressure. It is uncharged, so it will not destabilize the internal environment; non-ionic contrast agents have less impact on peripheral blood vessels, pulmonary circulation vessels and cardiac conduction systems, so there are fewer sequelae, and they can be used for cardiovascular angiography.
The global Medical Non-ionic Contrast Agent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Medical Non-ionic Contrast Agent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medical Non-ionic Contrast Agent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Medical Non-ionic Contrast Agent include GE Healthcare, Braco, Bayer, Guerbet, Leriva, Yangtze River Pharmaceutical (Group), Jiangsu Chia Tai-Tianqing Pharmaceutical, Jiangsu Hengrui Pharmaceuticals and Hainan Poly Pharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Medical Non-ionic Contrast Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Non-ionic Contrast Agent.
Report Scope
The Medical Non-ionic Contrast Agent market size, estimations, and forecasts are provided in terms of sales volume (K Liters) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Non-ionic Contrast Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Non-ionic Contrast Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Braco
Bayer
Guerbet
Leriva
Yangtze River Pharmaceutical (Group)
Jiangsu Chia Tai-Tianqing Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Hainan Poly Pharm
Beijing Beilu Pharmaceutical
Zhejiang Starry Pharmaceutical
Segment by Type
Iopamidol Injection
Iodixanol Injection
Iohexol Injection
Iopromide Injection
Other
Segment by Application
CT Enhanced Scan
Neurography
Angiography
Arthrography
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Non-ionic Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Non-ionic Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Due to the improvement of the chemical structure, non-ionic contrast agents have two main advantages over ionic contrast agents: most of the adverse reactions of contrast agents are related to high osmosis and charging. The distinguishing feature of non-ionic contrast agents is low osmotic pressure. It is uncharged, so it will not destabilize the internal environment; non-ionic contrast agents have less impact on peripheral blood vessels, pulmonary circulation vessels and cardiac conduction systems, so there are fewer sequelae, and they can be used for cardiovascular angiography.
The global Medical Non-ionic Contrast Agent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Medical Non-ionic Contrast Agent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medical Non-ionic Contrast Agent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Medical Non-ionic Contrast Agent include GE Healthcare, Braco, Bayer, Guerbet, Leriva, Yangtze River Pharmaceutical (Group), Jiangsu Chia Tai-Tianqing Pharmaceutical, Jiangsu Hengrui Pharmaceuticals and Hainan Poly Pharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Medical Non-ionic Contrast Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Non-ionic Contrast Agent.
Report Scope
The Medical Non-ionic Contrast Agent market size, estimations, and forecasts are provided in terms of sales volume (K Liters) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Non-ionic Contrast Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Non-ionic Contrast Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Braco
Bayer
Guerbet
Leriva
Yangtze River Pharmaceutical (Group)
Jiangsu Chia Tai-Tianqing Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Hainan Poly Pharm
Beijing Beilu Pharmaceutical
Zhejiang Starry Pharmaceutical
Segment by Type
Iopamidol Injection
Iodixanol Injection
Iohexol Injection
Iopromide Injection
Other
Segment by Application
CT Enhanced Scan
Neurography
Angiography
Arthrography
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Non-ionic Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Non-ionic Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Medical Non-ionic Contrast Agent Market Overview
1.1 Product Overview and Scope of Medical Non-ionic Contrast Agent
1.2 Medical Non-ionic Contrast Agent Segment by Type
1.2.1 Global Medical Non-ionic Contrast Agent Market Value Comparison by Type (2024-2030)
1.2.2 Iopamidol Injection
1.2.3 Iodixanol Injection
1.2.4 Iohexol Injection
1.2.5 Iopromide Injection
1.2.6 Other
1.3 Medical Non-ionic Contrast Agent Segment by Application
1.3.1 Global Medical Non-ionic Contrast Agent Market Value by Application: (2024-2030)
1.3.2 CT Enhanced Scan
1.3.3 Neurography
1.3.4 Angiography
1.3.5 Arthrography
1.3.6 Other
1.4 Global Medical Non-ionic Contrast Agent Market Size Estimates and Forecasts
1.4.1 Global Medical Non-ionic Contrast Agent Revenue 2019-2030
1.4.2 Global Medical Non-ionic Contrast Agent Sales 2019-2030
1.4.3 Global Medical Non-ionic Contrast Agent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Medical Non-ionic Contrast Agent Market Competition by Manufacturers
2.1 Global Medical Non-ionic Contrast Agent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Medical Non-ionic Contrast Agent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Medical Non-ionic Contrast Agent Average Price by Manufacturers (2019-2024)
2.4 Global Medical Non-ionic Contrast Agent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Non-ionic Contrast Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Non-ionic Contrast Agent, Product Type & Application
2.7 Medical Non-ionic Contrast Agent Market Competitive Situation and Trends
2.7.1 Medical Non-ionic Contrast Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Non-ionic Contrast Agent Players Market Share by Revenue
2.7.3 Global Medical Non-ionic Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Non-ionic Contrast Agent Retrospective Market Scenario by Region
3.1 Global Medical Non-ionic Contrast Agent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Medical Non-ionic Contrast Agent Global Medical Non-ionic Contrast Agent Sales by Region: 2019-2030
3.2.1 Global Medical Non-ionic Contrast Agent Sales by Region: 2019-2024
3.2.2 Global Medical Non-ionic Contrast Agent Sales by Region: 2025-2030
3.3 Global Medical Non-ionic Contrast Agent Global Medical Non-ionic Contrast Agent Revenue by Region: 2019-2030
3.3.1 Global Medical Non-ionic Contrast Agent Revenue by Region: 2019-2024
3.3.2 Global Medical Non-ionic Contrast Agent Revenue by Region: 2025-2030
3.4 North America Medical Non-ionic Contrast Agent Market Facts & Figures by Country
3.4.1 North America Medical Non-ionic Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Medical Non-ionic Contrast Agent Sales by Country (2019-2030)
3.4.3 North America Medical Non-ionic Contrast Agent Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Non-ionic Contrast Agent Market Facts & Figures by Country
3.5.1 Europe Medical Non-ionic Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Medical Non-ionic Contrast Agent Sales by Country (2019-2030)
3.5.3 Europe Medical Non-ionic Contrast Agent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Medical Non-ionic Contrast Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Non-ionic Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Medical Non-ionic Contrast Agent Sales by Country (2019-2030)
3.6.3 Asia Pacific Medical Non-ionic Contrast Agent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Medical Non-ionic Contrast Agent Market Facts & Figures by Country
3.7.1 Latin America Medical Non-ionic Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Medical Non-ionic Contrast Agent Sales by Country (2019-2030)
3.7.3 Latin America Medical Non-ionic Contrast Agent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical Non-ionic Contrast Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Non-ionic Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Medical Non-ionic Contrast Agent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Medical Non-ionic Contrast Agent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Non-ionic Contrast Agent Sales by Type (2019-2030)
4.1.1 Global Medical Non-ionic Contrast Agent Sales by Type (2019-2024)
4.1.2 Global Medical Non-ionic Contrast Agent Sales by Type (2025-2030)
4.1.3 Global Medical Non-ionic Contrast Agent Sales Market Share by Type (2019-2030)
4.2 Global Medical Non-ionic Contrast Agent Revenue by Type (2019-2030)
4.2.1 Global Medical Non-ionic Contrast Agent Revenue by Type (2019-2024)
4.2.2 Global Medical Non-ionic Contrast Agent Revenue by Type (2025-2030)
4.2.3 Global Medical Non-ionic Contrast Agent Revenue Market Share by Type (2019-2030)
4.3 Global Medical Non-ionic Contrast Agent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Medical Non-ionic Contrast Agent Sales by Application (2019-2030)
5.1.1 Global Medical Non-ionic Contrast Agent Sales by Application (2019-2024)
5.1.2 Global Medical Non-ionic Contrast Agent Sales by Application (2025-2030)
5.1.3 Global Medical Non-ionic Contrast Agent Sales Market Share by Application (2019-2030)
5.2 Global Medical Non-ionic Contrast Agent Revenue by Application (2019-2030)
5.2.1 Global Medical Non-ionic Contrast Agent Revenue by Application (2019-2024)
5.2.2 Global Medical Non-ionic Contrast Agent Revenue by Application (2025-2030)
5.2.3 Global Medical Non-ionic Contrast Agent Revenue Market Share by Application (2019-2030)
5.3 Global Medical Non-ionic Contrast Agent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GE Healthcare Medical Non-ionic Contrast Agent Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Braco
6.2.1 Braco Corporation Information
6.2.2 Braco Description and Business Overview
6.2.3 Braco Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Braco Medical Non-ionic Contrast Agent Product Portfolio
6.2.5 Braco Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Medical Non-ionic Contrast Agent Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Guerbet
6.4.1 Guerbet Corporation Information
6.4.2 Guerbet Description and Business Overview
6.4.3 Guerbet Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guerbet Medical Non-ionic Contrast Agent Product Portfolio
6.4.5 Guerbet Recent Developments/Updates
6.5 Leriva
6.5.1 Leriva Corporation Information
6.5.2 Leriva Description and Business Overview
6.5.3 Leriva Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Leriva Medical Non-ionic Contrast Agent Product Portfolio
6.5.5 Leriva Recent Developments/Updates
6.6 Yangtze River Pharmaceutical (Group)
6.6.1 Yangtze River Pharmaceutical (Group) Corporation Information
6.6.2 Yangtze River Pharmaceutical (Group) Description and Business Overview
6.6.3 Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Product Portfolio
6.6.5 Yangtze River Pharmaceutical (Group) Recent Developments/Updates
6.7 Jiangsu Chia Tai-Tianqing Pharmaceutical
6.6.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Corporation Information
6.6.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Description and Business Overview
6.6.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Product Portfolio
6.7.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
6.8 Jiangsu Hengrui Pharmaceuticals
6.8.1 Jiangsu Hengrui Pharmaceuticals Corporation Information
6.8.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.8.3 Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Product Portfolio
6.8.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.9 Hainan Poly Pharm
6.9.1 Hainan Poly Pharm Corporation Information
6.9.2 Hainan Poly Pharm Description and Business Overview
6.9.3 Hainan Poly Pharm Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hainan Poly Pharm Medical Non-ionic Contrast Agent Product Portfolio
6.9.5 Hainan Poly Pharm Recent Developments/Updates
6.10 Beijing Beilu Pharmaceutical
6.10.1 Beijing Beilu Pharmaceutical Corporation Information
6.10.2 Beijing Beilu Pharmaceutical Description and Business Overview
6.10.3 Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Product Portfolio
6.10.5 Beijing Beilu Pharmaceutical Recent Developments/Updates
6.11 Zhejiang Starry Pharmaceutical
6.11.1 Zhejiang Starry Pharmaceutical Corporation Information
6.11.2 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Description and Business Overview
6.11.3 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Product Portfolio
6.11.5 Zhejiang Starry Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Non-ionic Contrast Agent Industry Chain Analysis
7.2 Medical Non-ionic Contrast Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Non-ionic Contrast Agent Production Mode & Process
7.4 Medical Non-ionic Contrast Agent Sales and Marketing
7.4.1 Medical Non-ionic Contrast Agent Sales Channels
7.4.2 Medical Non-ionic Contrast Agent Distributors
7.5 Medical Non-ionic Contrast Agent Customers
8 Medical Non-ionic Contrast Agent Market Dynamics
8.1 Medical Non-ionic Contrast Agent Industry Trends
8.2 Medical Non-ionic Contrast Agent Market Drivers
8.3 Medical Non-ionic Contrast Agent Market Challenges
8.4 Medical Non-ionic Contrast Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
